329 related articles for article (PubMed ID: 26397159)
21. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue.
Ehrlund A; Mejhert N; Lorente-Cebrián S; Aström G; Dahlman I; Laurencikiene J; Rydén M
J Clin Endocrinol Metab; 2013 Mar; 98(3):E503-8. PubMed ID: 23393180
[TBL] [Abstract][Full Text] [Related]
22. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
23. Demethylation of the
Li H; Zhao J; Sun J; Tian C; Jiang Q; Ding C; Gan Q; Shu P; Wang X; Qin J; Sun Y
Mol Cancer Res; 2021 Sep; 19(9):1454-1464. PubMed ID: 34016745
[TBL] [Abstract][Full Text] [Related]
24. MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.
Revet I; Huizenga G; Koster J; Volckmann R; van Sluis P; Versteeg R; Geerts D
Cancer Lett; 2010 Mar; 289(2):195-207. PubMed ID: 19815336
[TBL] [Abstract][Full Text] [Related]
25. c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
Zhuang XP; Jin WW; Teng XD; Yuan ZZ; Lin QQ; Xu ST
Eur J Gynaecol Oncol; 2015; 36(3):255-9. PubMed ID: 26189249
[TBL] [Abstract][Full Text] [Related]
26. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
[TBL] [Abstract][Full Text] [Related]
28. Expression and clinical significance of sperm-associated antigen 9 in patients with endometrial carcinoma.
Yu P; Yan L; Zhang H; Lin X; Zhao X
Int J Gynecol Cancer; 2012 Jan; 22(1):87-93. PubMed ID: 22146769
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
Liu Y; Patel L; Mills GB; Lu KH; Sood AK; Ding L; Kucherlapati R; Mardis ER; Levine DA; Shmulevich I; Broaddus RR; Zhang W
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214561
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
Risinger JI; Maxwell GL; Chandramouli GV; Aprelikova O; Litzi T; Umar A; Berchuck A; Barrett JC
Cancer Res; 2005 Jun; 65(12):5031-7. PubMed ID: 15958545
[TBL] [Abstract][Full Text] [Related]
31. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
[TBL] [Abstract][Full Text] [Related]
32. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
[TBL] [Abstract][Full Text] [Related]
33. Mutations in sFRP1 or sFRP4 are not a common cause of craniotubular hyperostosis.
Boudin E; Piters E; Fijalkowski I; Stevenheydens G; Steenackers E; Kuismin O; Moilanen JS; Mortier G; Van Hul W
Bone; 2013 Jan; 52(1):292-5. PubMed ID: 23044044
[TBL] [Abstract][Full Text] [Related]
34. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA
Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464
[TBL] [Abstract][Full Text] [Related]
36. Dynamic decreased expression and hypermethylation of secreted frizzled-related protein 1 and 4 over the course of pulmonary fibrosis in mice.
Zhou J; Yi Z; Fu Q
Life Sci; 2019 Feb; 218():241-252. PubMed ID: 30586565
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of tgfb1 protein in endometrioid adenocarcinoma.
Soufla G; Sifakis S; Porichis F; Spandidos DA
Eur J Clin Invest; 2013 Jan; 43(1):79-90. PubMed ID: 23176363
[TBL] [Abstract][Full Text] [Related]
38. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex.
Suwa T; Chen M; Hawks CL; Hornsby PJ
J Endocrinol; 2003 Jul; 178(1):149-58. PubMed ID: 12844346
[TBL] [Abstract][Full Text] [Related]
39. CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.
Fang Y; Li Z; Wang X; Zhang S
Tumour Biol; 2012 Dec; 33(6):2299-306. PubMed ID: 22923389
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic value of WISP-1 in patients with endometrial endometrioid adenocarcinoma.
Tang Q; Jiang X; Li H; Lin Z; Zhou X; Luo X; Liu L; Chen G
J Obstet Gynaecol Res; 2011 Jun; 37(6):606-12. PubMed ID: 21564416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
